FTO and Renal neoplasm: Interestingly, the recent integrated molecular analyses of The Cancer Genome Atlas (TCGA) emphasized the metabolic deregulation in the several renal tumors, with erasers FTO and ALKBH5 specifically associated with metabolic reprogramming [30,31,32].